Publication at Faculty of Medicine in Pilsen |
2017
Abstract
A great progress has been made in the treatment of relapse-remitting multiple sclerosis in the last couple years. The arrival of newhighly efficient drugs rises discussion about choosing the right strategy, how to treat patients with MS.
It is generally well known,that the key to successful treatment is the early initiation. That gives the basis to two main opinions on which kind of therapyto choose for each patient.
That is the purpose of this article, which focuses deeply on the concepts of escalation and inductiontherapy of MS using the new drugs.